View allAll Photos Tagged GeneTherapy
The Beast, a master of intrigue. The antichrist, pretends to be a man of peace. The worthless shepherd, makes a worthless peace treaty. The man of lawlessness, breaks his peace treaty. The son of destruction, a conqueror bent on conquest.
When the day comes for your mandatory microchip, will you get your implant? If you can’t buy or sell or work or participate in society without it, will you take the jab? What if you are declared an enemy of the state, a terrorist, or an enemy of humanity, if you reject it? Will you get it then? What if the death penalty is given to those who refuse the smartchip? Will you take it then? What if this means death by the guillotine? Will you submit? What if eternity in hell is the punishment you will get for receiving the Mark of the Beast? Will you still inject it? Will you walk in fear or faith? Will you walk in light or darkness? Will you walk in lies or truth? Will you follow Christ or the antichrist?
Dr. Yuval Noah Harari: “Previously surveillance was mainly above the skin, now it is going under the skin.”
Matthew 7:13 “Enter through the narrow gate. For wide is the gate and broad is the road that leads to destruction, and many enter through it.”
A British government website says that the covid vaccines are a gene therapy:
“Lipids are an essential component in COVID vaccines as well as other gene therapies.”
www.gov.uk/government/news/government-to-provide-shot-in-...
Bayer president: The mRNA vaccines are a gene therapy:
www.youtube.com/watch?v=P9qPDhn3xf8
Burnaby gene-therapy company starting trial for oral COVID-19 vaccine:
www.youtube.com/watch?v=rpB0QFkgess
Pfizer vaccine becomes DNA in human liver cells (Swedish Study):
www.youtube.com/watch?v=GC9qqpwCb7U
Spike Protein Goes to Nucleus and Impairs DNA Repair:
www.youtube.com/watch?v=-SYL-iU0E9Q
All roads lead down the path to depopulation and transhumanism…AKA Darwinism (evolution and survival of the fittest), which is not only antichrist but will also lead to the Antichrist himself and the Mark of the Beast…the age of transhumanism. Transhumanism will not happen over night, but it is coming quicker then most think. Several mouths ago I read an article on how scientists want to make GMO foods with the covid vaccine in them. GMO foods are unnatural to the human body and over time will either genetically modify us to some extent or make us unhealthy…just ask Monsanto. When you try to play God, something bad will happen in the end…judgment!
The vaccine can make DNA through your liver. The spike protein can impair the repairing of your DNA when it breaks. Now what if we add graphene to the vaccine, along with who knows what? Nanotechnology here we come! It looks like the ground work is being laid for transhumanism. In the end they will add a microchip implant. Over the years I have read several news articles talking about microchipping the population. You should read the Bible to see what is coming. In the Tribulation Period many will become Christians when they see Bible prophecy unfolding, but they will pay with their lives.
The biopower and biopolitics of the biotechnocracy with its nonexistent bioethics of biotechnology. The vaccine gene therapy, altering DNA, manipulating basic biology with spike protein. We will biohack the proteins and DNA that are central to your biology. Human genetic engineering will lead to artificial intelligence and bioengineering. AI and biotechnology will be the end of the real you. Take the jab, take the biohazard, receive your biopassport. Get your biochip, become a bionerd. Don’t be biosensitive; don’t let the bioink leak from yours eyes as you cry out in joy. We wouldn’t want your embedded biosensors to send out an emergency alert, now would we? Synthetic biology and biological data. 666 and the biosurveillance system. Bio-serfdom: equality for all! Let’s eradicate poverty, let’s make y’all biodigital slaves! If you don’t believe transhumanism is right around the corner, then check out the government website below.
Here is an article on the Canadian government website called: Exploring Biodigital Convergence
horizons.gc.ca/en/2020/02/11/exploring-biodigital-converg...
Here is one for you Americans: In science we trust!
“I pledge allegiance to the Flag of the United Nations, and to the New World Order for which it stands, one post-nation under pseudoscience, divisible, without liberty and justice for all.”
Abort millions of babies…oh wait…now we don’t have enough skilled labour, and who is going to pay taxes to look after our ageing population? We have low birth rates, so let’s bring in large numbers of immigrants. Multiculturalism, let’s make you a melting pot of people. We will erode your culture and values…and who needs borders? The future is tranhumanism! Humans will evolve until there is no race or gender or reproduction…as for culture and borders, they will no longer exist…it’s all part of the plan…divide, conquer, and assimilate into the transhuman revolution. Humans will continue to evolve until they no longer resemble humans. Humans will become extinct. Survival of the fittest! Many will die in this evolution of man and AI, but some will adapt and survive. You will be owned like cattle, and once your purpose is fulfilled, we will get rid of you…like we do to those in the womb today…life isn’t sacred…especially if you aren’t even human…just some sort of parasite. Welcome to the New World Order of transhumanism!
Thankfully we have a Saviour, so things will only go so far. The Mark of the Beast is as far as transhumanism will get. When Jesus returns He will throw all the transhumans into hell. That will be the end of transhumanism. There is no eternal life in transhumanism, except for eternal life in hell.
1 Corinthians 3:18-20 “Stop deceiving yourselves. If you think you are wise by this world’s standards, you need to become a fool to be truly wise. For the wisdom of this world is foolishness to God. As the Scriptures say, ‘He traps the wise in the snare of their own cleverness.’ And again, ‘The LORD knows the thoughts of the wise; he knows they are worthless.’”
A study was published in the July 8 issue of Science Translational Medicine that demonstrated gene therapy as an effective way to improve hearing in patients with two genes linked to genetic prelingual deafness, or hearing loss that occurs before a child learns to speak. The study focused on deafness caused by defects in the Transmembrane-like channel 1 (TMC1), which is a protein that helps convert sounds into electrical signals for the brain to interpret. Defects in the Tmc1 gene are a common cause of genetic deafness, accounting for 4 to 8 percent of cases.
Credit: Darryl Leja, NHGRI.
Riley had metaphorically zipped up her boots but now was hoping, quite literally, to go back to her roots. She had been vegan for a number of years now but had decided to take that final fateful step and go full vegetal. This would, in effect, consist of experimental gene replacement therapy whereby she'd be spliced with the genome of her favourite plant, the aubergine. It's too early to tell whether or not the treatment will be effective but she reckons her chakras are realigning and has certainly taken on an interesting sheen...
'Going back to my roots' is on classy A2 paper and made using the magic of stencils, spray paint, paint pen, dymo and imagination. She's available to a good home so drop us a line or she'll be on our website soon (www.id-iom.com).
Cheers
id-iom
Scientists at NIH's National Eye Institute have developed a promising gene therapy strategy for a form of Leber congenital amaurosis (LCA), a rare disease that causes severe vision loss in childhood. The scientists tested their approach using lab-made retinal tissues built from patient cells, called retinal organoids, one of which is pictured here. ⠀
⠀
Read more: www.nih.gov/news-events/news-releases/researchers-use-pat...
Credit: Anand Swaroop, Ph.D., NEI/NIH
Companion diagnostic tests show which patients could be helped by a drug and which patients would not benefit, and could even be harmed.
The recent approval of a genetic test to help doctors prescribe a drug that treats colorectal cancer is just one example of the increasing importance of companion diagnostic tests in personalized medicine to ensure the safety and effectiveness of targeted therapies. Read this FDA Consumer Update to learn more.
This graphic is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/
FDA graphic by Michael J. Ermarth
The gene therapy involved inserting a functional copy of the NPC1 gene into mice with the disease. The treated animals were then found to have less severe NPC1 symptoms. The NIH mouse study could lead to human clinical trials.
More information: www.nih.gov/news-events/news-releases/gene-therapy-shows-...
Credit: National Human Genome Research Institute, National Institutes of Health
Scientists can now modify genes or replace faulty genes with healthy ones to treat, cure or prevent a disease or medical condition. Gene therapy can be performed both inside and outside the body. This graphic illustrates in simple terms how gene therapy works inside the body. Read the FDA Consumer Update to learn more.
This infographic is an original FDA creation and in the public domain. It may be shared, downloaded and redistributed without restriction. Credit to FDA is appreciated but not required.
FDA infographic by Michael J. Ermarth
Riley had metaphorically zipped up her boots but now was hoping, quite literally, to go back to her roots. She had been vegan for a number of years now but had decided to take that final fateful step and go full vegetal. This would, in effect, consist of experimental gene replacement therapy whereby she'd be spliced with the genome of her favourite plant, the aubergine. It's too early to tell whether or not the treatment will be effective but she reckons her chakras are realigning and has certainly taken on an interesting sheen...
'Going back to my roots' is on classy A2 paper and made using the magic of stencils, spray paint, paint pen, dymo and imagination. She's available to a good home so drop us a line or she'll be on our website soon (www.id-iom.com).
Cheers
id-iom
Injecting a shot of genes into the brain’s ventricular plumbing system may be an effective long term method for treating neurological disorders.
Press release: www.nih.gov/news-events/news-releases/batten-disease-may-...
Credit: Luis Tecedor and Beverly L. Davidson at Children's Hospital of Philadelphia
This image is not owned by the NIH. It is shared with the public under license. If you have a question about using or reproducing this image, please contact the creator listed in the credits. All rights to the work remain with the original creator.
NIH funding from: National Institute of Neurological Disorders and Stroke (NINDS), National Eye Institute (NEI)
You know what; there is a company up in Iceland that has got hold of the medical records of everyone on that island like, and they know about every disease that everyone has ever had. Tonsillitis, high blood pressure, multiple sclerosis, diabetes, schizophrenia; you name it, they know it.
No shit man??? That’s way weird.
Yeah!!! and what they have done is get samples of folks DNA, and looked for certain genes, and come up with the idea that certain genes produce certain diseases. I mean to say, they can even take a sample from a baby in the womb, and tell you if its going to be a spastic or whatever.
Man that’s capital Weird!!! Double hairy gnarly man.
Well they were not making enough money with the DNA analysis thing, so they sell all this information to some big insurance company. And you know what man, they begin to use it to evaluate risks when they sell health insurance. You know, like, if you have a heart attack gene there in no way you are going to get life insurance.
Bummer man, No way!!!
Capital way man. It’s all about risk evaluation, and the next thing you know it’s about crime prevention. I mean to say if the police got a hold of our DNA we’d be shoved straight in the slammer, faster than shit off a hot shovel.
Man your freaking me out, like major big time. Bad vibes man.
Mega mega major freak I’m telling you. Like would you want to know if you were a Tay-Sachs carrier? You are screwed if you get one base pair wrong. Just one letter wrong. Like, one in twenty five Ashkenazi Jews are carriers of Tay-Sachs disease, and they screen themselves so they don’t team up with the wrong partner.
Holy shit, you mean no more screwing around?
Next thing you know there’s a eugenics programme going, and marriage laws about who can wed and what not, and after that, to get it right, people are having designer babies. You know like, they’d have babies with the brains of Albert Einstein and the bodies of Britney Spears.
But what if the babies got Britney’s brains… that would be way cool man, a world of singing babies.
Yeah that would be way cool!!! Babies singing hit me one more time. There must be, just gotta be a singing gene out there. Some protein that codes for good vocal chords, some bit of DNA that gives you perfect pitch. They could inject it into all of those losers that audition for pop-idol.
You mean like a talent gene??? Right on!!!
Exactly!!! You would never need to practice the piano, you would just sit down and play it, and the French could have a language gene implanted so they would be forced to speak something other than Froggie.
Crescent fresh idea dude. They should go for it major like!!!
You want to know something really weird? Like some dude in Japan took the notes from the “Death March” by Mozart and used some strange algorithm to convert them into a protein sequence, and then, when he searched some protein database in Switzerland he found out that the notes had been transcribed into a protein that was responsible for cancer. You get it?
Musical DNA like??? Incredible with a capital in!!!
Exactly!!! So here’s my plan, I mean to say, I am thinking out of the box here. Tossin’ a few ideas around. It’s simple really. You know that serotonin or something like that, some dopamine thing, some chemical from this spliff, or just plain old booze, alters the way we feel, readjusts our brain chemistry. Well we reverse the process, and we turn the chemical or protein or whatever, into music.
Like music is the drug??? That rawks man!!! Kool!!! Sure as hell would knock seven colours of shit out of MTV. We could make millions… Wicked… Yeah!!!
Mega Kool dudester!!!
Mesa redonda: "Cell, gene and tissue engineering-based technologies and platforms".
Moderador: Shomi Bhattacharya, Director, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER) / Scientific Director, Andalusian Human Genome Sequencing Centre (CASEGH) / Professor of Experimental Ophthalmology and Head of Molecular Genetics, Institute of Ophthalmology, University College of London.
Ponentes: Robert Brown, James Kirkpatrick, Jose Cibelli, Francisco Martín, Blanca Miranda, Javier Santoyo-López
Mesa redonda: "Cell, gene and tissue engineering-based technologies and platforms"
Moderador: Shomi Bhattacharya, Director, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER) / Scientific Director, Andalusian Human Genome Sequencing Centre (CASEGH) / Professor of Experimental Ophthalmology and Head of Molecular Genetics, Institute of Ophthalmology, University College of London.
Ponentes: Robert Brown, James Kirkpatrick, Jose Cibelli, Francisco Martín, Blanca Miranda, Javier Santoyo-López
Riley had metaphorically zipped up her boots but now was hoping, quite literally, to go back to her roots. She had been vegan for a number of years now but had decided to take that final fateful step and go full vegetal. This would, in effect, consist of experimental gene replacement therapy whereby she'd be spliced with the genome of her favourite plant, the aubergine. It's too early to tell whether or not the treatment will be effective but she reckons her chakras are realigning and has certainly taken on an interesting sheen...
'Going back to my roots' is on classy A2 paper and made using the magic of stencils, spray paint, paint pen, dymo and imagination. She's available to a good home so drop us a line or she'll be on our website soon (www.id-iom.com).
Cheers
id-iom
Dieser Doktorhut hat eine Geschichte - die Dissertation dazu gibt's auf Qucosa: tud.qucosa.de. Die URN dieser Dissertation lautet urn:nbn:DE:bsz:14-qucosa-102054.
Ein Bild mit Hut sagt mehr als tausend Worte! Deshalb sammeln wir Fotos individueller Dr.Hüte, die mit einer Open Access-Veröffentlichung auf www.qucosa.de verlinkt sind – auf Flickr, im SLUBlog und auf Twitter. Wir möchten damit erreichen, dass noch mehr Forschungsergebnisse elektronisch mit Open Acccess veröffentlicht werden, damit Wissen einfach geteilt und genutzt werden kann. Und Neugier wecken, denn unter jedem Doktorhut stecken Ideen, Anekdoten, Köpfe und die sprichwörtlichen Mühen der Ebene.
Haben Sie bereits beides erworben oder kennen jemand, der jemand kennt, die oder der einen Dr.-Hut mit Open-Access-Link zur eigenen Diss hat? Oder möchten Sie selbst Ihre Doktorarbeit nachträglich online veröffentlichen? Dann bitten wir Sie um eine Nachricht an das Qucosa-Team der SLUB.
Mesa redonda: "Cell, gene and tissue engineering-based technologies and platforms".
Moderador: Shomi Bhattacharya, Director, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER) / Scientific Director, Andalusian Human Genome Sequencing Centre (CASEGH) / Professor of Experimental Ophthalmology and Head of Molecular Genetics, Institute of Ophthalmology, University College of London.
Ponentes: Robert Brown, James Kirkpatrick, Jose Cibelli, Francisco Martín, Blanca Miranda, Javier Santoyo-López
Dr. Pearl O’Rourke began her career as a pediatric critical care physician. She was active in clinical research and served many years as an Institutional Review Board member. After completing a Robert Wood Johnson Health Policy fellowship she worked in the Office of Science Policy at the National Institutes of Health on issues such as privacy, gene therapy, embryonic stem cells, and genetic discrimination. She works now to support the regulatory and ethical oversight of human research and the responsible conduct of research, and has been a strong advocate on behalf of rare diseases.
For more information visit www.fda.gov/orphan.
This is an illustration of this gene therapy approach for Pompe disease, a deadly, inherited muscle disorder caused by a faulty gene. This image depicts a modified virus, called rAAV 8, being injected into an individual and carrying a healthy gene to the liver. Once in the liver, the gene produces a missing enzyme, called GAA, which goes to the muscles and helps them work. Based on mouse studies, the researchers also expect the gene therapy to train the body’s immune system to recognize GAA and not attack it.
Credit: National Center for Advancing Translational Sciences
A medium Americano with a shot of vanilla Syrup. The taste of which reminds me of a drink common in Colombia. Known as Campecino, if you order one of these there you will receive a similar tasting black coffee with a sweet taste.
In the background, my revision notes for GeneTherapy. My final exams are in less than 3 weeks.
Farah Tasnim, Premio a la Mejor Comunicación Oral por su comunicación "Characterization and engineering of primary human renal cells for applications in in vitro toxicology and kidney tissue engineering"
"Industry Presentations"
Moderador: Rafael Camacho, CEO Fundación Genoma España, Madrid, SPAIN
Ponentes:
· Josep Vergés -PharmaScience, Bioiberica-
· Eduardo Anitua -B.T.I.-
· Jose L. Mateos -Miltenyi Biotec España-
· Javier Alonso -Ingeclima-
Laser Cut Acrylic, Vellum,
Masonite
Gene Therapy concerns the human p53 gene. A tumor suppressing oncogene, the p53 gene is crucial in the regulation of the human cell cycle, and a leading defense in the prevention of Cancer. The boxes house the individual base nucleotides for the gene to properly function, and allows the user to simulate genetic mutation through the rearrangement of their order. This rearrangement occurs in life as the result of exposure to radiation, UV rays, and other chemical stimulus that disrupts the p53 gene’s status, and can lead to its loss of function, and as a result, uncontrolled production of cells which lead to tumor formation and cancer. 50% of all cancerous tumors contain p53 mutations, and as little as one single “missense” mutation (the kind simulated by the moving of these blocks) can lead to this outcome. The inheritance of our genes from our families, and their passing on to posterity is the every burgeoning cycle of life, and the fragility of their composition can tear apart the families that contain them. The images on the bottoms of the boxes represent the inheritance of these genes from family members, and are broken when rearranged.
Armand Keating:
· President of the American Society of Hematology
· Director, Cell Therapy Program and Philip S. Orsino Facility for Cell Therapy, Princess Margaret Hospital/Ontario Cancer Institute
· Professor of Medicine / Professor, Institute of Biomaterials and Biomedical Engineering
· Director, Division of Hematology
· Epstein Chair in Cell Therapy and Transplantation, University of Toronto
La ceremonia de apertura del I Simposio Internacional en Terapias Avanzadas, corrió a cargo del secretario general de Calidad e Innovación de la Consejería de Salud y Bienestar Social, José Luis Rocha, y del vicerrector de investigación de la Universidad de Granada, Ignacio Molina
Laser Cut Acrylic, Vellum,
Masonite
Gene Therapy concerns the human p53 gene. A tumor suppressing oncogene, the p53 gene is crucial in the regulation of the human cell cycle, and a leading defense in the prevention of Cancer. The boxes house the individual base nucleotides for the gene to properly function, and allows the user to simulate genetic mutation through the rearrangement of their order. This rearrangement occurs in life as the result of exposure to radiation, UV rays, and other chemical stimulus that disrupts the p53 gene’s status, and can lead to its loss of function, and as a result, uncontrolled production of cells which lead to tumor formation and cancer. 50% of all cancerous tumors contain p53 mutations, and as little as one single “missense” mutation (the kind simulated by the moving of these blocks) can lead to this outcome. The inheritance of our genes from our families, and their passing on to posterity is the every burgeoning cycle of life, and the fragility of their composition can tear apart the families that contain them. The images on the bottoms of the boxes represent the inheritance of these genes from family members, and are broken when rearranged.
Beyond the Diagnosis CEO and Founder Patricia Weltin (left) presents the newest painting to the collection of art featuring rare disease patients. The painting by artist Jota Leal features 9-year-old Amber (right), who is part of a gene therapy trial at the NIH Clinical Center and a resident of The Children’s Inn at NIH. The portrait was unveiled at Rare Disease Day at NIH on Feb. 28, 2019. Amber’s parents, Miguel and Leticia, stand on either side of the portrait with Stephanie Feinberg of The Children’s Inn at NIH.
Credit: Daniel Soñé Photography
Nine-year-old Amber (center), who is part of a gene therapy trial at the NIH Clinical Center and a resident of The Children’s Inn at NIH, poses with her parents, Miguel and Leticia (right); Shazia Ahmad (left); and Jennie Lucca, CEO of The Children’s Inn at NIH, at Rare Disease Day at NIH on Feb. 28, 2019.
Credit: Daniel Soñé Photography
El Premio a mejor Comunicación Oral en el I Simposio Internacional en Terapias Avanzadas fue otorgado a Farah Tasnim, de manos de Natividad Cuende y Antonio Campos
Chester B. Whitley, Ph.D., M.D., Professor, Gene Therapy Center, Department of Pediatrics and Experimental and Clinical Pharmacology, University of Minnesota; Principal Investigator, Lysosomal Disease Network speaks at Rare Disease Day at NIH 2018.
Credit: Daniel Soñé Photography, LLC
Javier Montero, Director, Technology Transfer Office of the Andalusian Public Healthcare System. Fundación Progreso y Salud, Seville, SPAIN
Mesa redonda: "Education and training in cell and gene-based therapies"
Moderador: Indalecio Sánchez, Dean of the School of Medicine. Professor of Anatomy and Embriology, University of Granada
Ponentes:
· Robert Brown
· Miguel Alaminos
· Jan A. Nolta
· Natividad Cuende
· Wolfgang J. Parak
Laser Cut Acrylic, Vellum,
Masonite
Gene Therapy concerns the human p53 gene. A tumor suppressing oncogene, the p53 gene is crucial in the regulation of the human cell cycle, and a leading defense in the prevention of Cancer. The boxes house the individual base nucleotides for the gene to properly function, and allows the user to simulate genetic mutation through the rearrangement of their order. This rearrangement occurs in life as the result of exposure to radiation, UV rays, and other chemical stimulus that disrupts the p53 gene’s status, and can lead to its loss of function, and as a result, uncontrolled production of cells which lead to tumor formation and cancer. 50% of all cancerous tumors contain p53 mutations, and as little as one single “missense” mutation (the kind simulated by the moving of these blocks) can lead to this outcome. The inheritance of our genes from our families, and their passing on to posterity is the every burgeoning cycle of life, and the fragility of their composition can tear apart the families that contain them. The images on the bottoms of the boxes represent the inheritance of these genes from family members, and are broken when rearranged.
Patricia Weltin, CEO and founder of Beyond the Diagnosis; and NIH Director Francis S. Collins, M.D., Ph.D., stand by the portrait of 9-year-old Amber, who has a rare disease, is part of a gene therapy trial at the NIH Clinical Center and is a resident of the Children’s Inn. The portrait was unveiled during Rare Disease Day at NIH on Feb. 28, 2019.
Credit: Daniel Soñé Photography
A sample of the vector used in a study on the effect of gene therapy on haemophilia B
Read about this story on UCL News: bit.ly/v5xtmE
Watch the video on UCLTV: youtu.be/11maHFwC35s
Find out more at UCL Sound: snd.sc/zWXkBX
C. James Kirkpatrick, Professor & Director Institute of Pathology University Medical Center. Johannes Gutenberg University, Mainz, GERMANY
Laser Cut Acrylic, Vellum,
Masonite
Gene Therapy concerns the human p53 gene. A tumor suppressing oncogene, the p53 gene is crucial in the regulation of the human cell cycle, and a leading defense in the prevention of Cancer. The boxes house the individual base nucleotides for the gene to properly function, and allows the user to simulate genetic mutation through the rearrangement of their order. This rearrangement occurs in life as the result of exposure to radiation, UV rays, and other chemical stimulus that disrupts the p53 gene’s status, and can lead to its loss of function, and as a result, uncontrolled production of cells which lead to tumor formation and cancer. 50% of all cancerous tumors contain p53 mutations, and as little as one single “missense” mutation (the kind simulated by the moving of these blocks) can lead to this outcome. The inheritance of our genes from our families, and their passing on to posterity is the every burgeoning cycle of life, and the fragility of their composition can tear apart the families that contain them. The images on the bottoms of the boxes represent the inheritance of these genes from family members, and are broken when rearranged.
Laser Cut Acrylic, Vellum,
Masonite
Gene Therapy concerns the human p53 gene. A tumor suppressing oncogene, the p53 gene is crucial in the regulation of the human cell cycle, and a leading defense in the prevention of Cancer. The boxes house the individual base nucleotides for the gene to properly function, and allows the user to simulate genetic mutation through the rearrangement of their order. This rearrangement occurs in life as the result of exposure to radiation, UV rays, and other chemical stimulus that disrupts the p53 gene’s status, and can lead to its loss of function, and as a result, uncontrolled production of cells which lead to tumor formation and cancer. 50% of all cancerous tumors contain p53 mutations, and as little as one single “missense” mutation (the kind simulated by the moving of these blocks) can lead to this outcome. The inheritance of our genes from our families, and their passing on to posterity is the every burgeoning cycle of life, and the fragility of their composition can tear apart the families that contain them. The images on the bottoms of the boxes represent the inheritance of these genes from family members, and are broken when rearranged.
Mesa redonda sobre las actuales aplicaciones clínicas y las perspectivas futuras de las terapias avanzadas, moderada por la investigadora principal del Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica, Genyo, la profesora Marta Alarcón Riquelme
Dos asistentes al I Simposio Internacional en Terapias Avanzadas se familiarizan con la máquina de citometría de flujo
Jan A. Nolta:
· Director, Stem Cell Program and Institute for Regenerative Cures
· Scientific Director, UC Davis GMP Facility
· Editor, Stem Cells Journal. University of California, Davis, USA
Todas las comunicaciones poster se publicaron en el suplemento especial de la revista "Histology and Histopathology"
Natividad Cuende:
· Executive Director of the Andalusian Initiative for Advanced Therapies. Andalusian Ministry of Health
· Deputy Director of the Andalusian Transplant Coordination. Andalusian Health Service
· Director of the University of Granada Master in Manufacturing of Advanced Therapy Medicinal Products